Estor sarà presente al 35° VICENZA COURSE on AKI and CRRT, 13-16 giugno 2017, Vicenza.
Il 14 giugno alle ore 17.30, il Prof. Massimo Antonelli, Presidente della Società Europea di Terapia Intensiva (ESICM) e membro dello scientific steering committee dello studio EUPHRATES, presenterà i risultati dello studio EUPHRATES in merito alla terapia con Polimixina B in emoperfusione nei pazienti con shock settico.
La presentazione sarà trasmessa in diretta web all’indirizzo http://stream6.ondastreaming.eu/, disponibile gratuitamente a tutti coloro che desiderano assistere alla trasmissione on-line previa registrazione, secondo un press release da Spectral Medical Inc.
Program:
Wednesday 14th June – 16.50-18.30 – Sala Palladio
Session 4: HEART, LUNG AND KIDNEY
Chairmen: M.K. Nadim – C. Hobson
Mechanical ventilation and the kidney
– K. Liu
AKI in cardiac surgery
– N. Katz
Results of the EUPHRATES trial
– M. Antonelli
Adjourn
Thursday 15th June – 10.40-13.00 – Sala Palladio
Session 6: AKI IN SEPSIS: MANAGEMENT STRATEGIES
Chairmen: L. Chawla – J. Koyner
From sorbent hemoperfusion to endotoxin removal
– C. Ronco
CPFA: promises and results
– G. Castellano
HCO membranes and sorbents for protection from tubular cell injury
– V. Cantaluppi
Safety and efficacy of CytoSorb – clinical experiences and current evidence
– S. Mitzner
Extracorporeal membrane separation techniques for sepsis
– W. Clark
Combined ECMO and CRRT in sepsis
– A. Bihorac
Discussion
Friday 16th June – 09.20-11.10 – Sala Palladio
Session 10: CRRT AND BEYOND
Chairmen: P. Honoré – S. Mitzner
Choice of vascular access and anticoagulation for CRRT
– M. Schetz
Dose and timing of CRRT according to precision medicine
– A. Zarbock
Biomarkers of recovery: can we predict successful CRRT discontinuation?
– L. Forni
Extracorporeal CO2 removal: rationale and techniques
– M. Maggiorini
Cloud-based data collection for big data generation
– C. Ronco
Discussion